• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯并嘧啶激酶抑制剂SGI-1776可诱导慢性淋巴细胞白血病细胞凋亡。

Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.

作者信息

Chen Lisa S, Redkar Sanjeev, Bearss David, Wierda William G, Gandhi Varsha

机构信息

Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Blood. 2009 Nov 5;114(19):4150-7. doi: 10.1182/blood-2009-03-212852. Epub 2009 Sep 4.

DOI:10.1182/blood-2009-03-212852
PMID:19734450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2774551/
Abstract

Pim kinases are involved in B-cell development and are overexpressed in B-cell chronic lymphocytic leukemia (CLL). We hypothesized that Pim kinase inhibition would affect B-cell survival. Identified from a screen of imidazo[1,2-b]pyridazine compounds, SGI-1776 inhibits Pim-1, Pim-2, and Pim-3. Treatment of CLL cells with SGI-1776 results in a concentration-dependent induction of apoptosis. To elucidate its mechanism of action, we evaluated the effect of SGI-1776 on Pim kinase function. Unlike in replicating cells, phosphorylation of traditional Pim-1 kinase targets, phospho-Bad (Ser112) and histone H3 (Ser10), and cell-cycle proteins were unaffected by SGI-1776, suggesting an alternative mechanism in CLL. Protein levels of total c-Myc as well as phospho-c-Myc(Ser62), a Pim-1 target site, were decreased after SGI-1776 treatment. Levels of antiapoptotic proteins Bcl-2, Bcl-X(L), XIAP, and proapoptotic Bak and Bax were unchanged; however, a significant reduction in Mcl-1 was observed that was not caused by caspase-mediated cleavage of Mcl-1 protein. The mechanism of decline in Mcl-1 was at the RNA level and was correlated with inhibition of global RNA synthesis. Consistent with a decline in new RNA synthesis, MCL-1 transcript levels were decreased after treatment with SGI-1776. These data suggest that SGI-1776 induces apoptosis in CLL and that the mechanism involves Mcl-1 reduction.

摘要

Pim激酶参与B细胞发育,且在B细胞慢性淋巴细胞白血病(CLL)中过表达。我们推测Pim激酶抑制会影响B细胞存活。从咪唑并[1,2 - b]哒嗪化合物筛选中鉴定出的SGI - 1776可抑制Pim - 1、Pim - 2和Pim - 3。用SGI - 1776处理CLL细胞会导致浓度依赖性的凋亡诱导。为阐明其作用机制,我们评估了SGI - 1776对Pim激酶功能的影响。与在增殖细胞中不同,传统Pim - 1激酶靶点磷酸化的Bad(Ser112)和组蛋白H3(Ser10)以及细胞周期蛋白不受SGI - 1776影响,提示在CLL中有另一种机制。SGI - 1776处理后,总c - Myc以及Pim - 1靶点位点磷酸化的c - Myc(Ser62)的蛋白水平降低。抗凋亡蛋白Bcl - 2、Bcl - X(L)、XIAP以及促凋亡蛋白Bak和Bax的水平未改变;然而,观察到Mcl - 1显著降低,这并非由半胱天冬酶介导的Mcl - 1蛋白裂解所致。Mcl - 1下降的机制在RNA水平,且与整体RNA合成的抑制相关。与新RNA合成下降一致,用SGI - 1776处理后MCL - 1转录水平降低。这些数据表明SGI - 1776在CLL中诱导凋亡,且其机制涉及Mcl - 1减少。

相似文献

1
Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.吡咯并嘧啶激酶抑制剂SGI-1776可诱导慢性淋巴细胞白血病细胞凋亡。
Blood. 2009 Nov 5;114(19):4150-7. doi: 10.1182/blood-2009-03-212852. Epub 2009 Sep 4.
2
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia.Pim 激酶抑制剂 SGI-1776 对急性髓系白血病细胞的细胞毒性作用机制。
Blood. 2011 Jul 21;118(3):693-702. doi: 10.1182/blood-2010-12-323022. Epub 2011 May 31.
3
Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.转录和翻译是套细胞淋巴瘤中 Pim 激酶抑制剂 SGI-1776 的主要靶点。
Blood. 2012 Oct 25;120(17):3491-500. doi: 10.1182/blood-2012-02-412643. Epub 2012 Sep 6.
4
Biological effects of the Pim kinase inhibitor, SGI-1776, in multiple myeloma.Pim 激酶抑制剂 SGI-1776 在多发性骨髓瘤中的生物学效应。
Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2(0 2):S317-29. doi: 10.1016/j.clml.2013.05.019. Epub 2013 Aug 27.
5
Biochemical changes of salivary gland adenoid cystic carcinoma cells induced by SGI-1776.SGI-1776诱导唾液腺腺样囊性癌细胞的生化变化
Exp Cell Res. 2017 Mar 15;352(2):403-411. doi: 10.1016/j.yexcr.2017.02.029. Epub 2017 Feb 20.
6
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms.Pim 激酶抑制剂 SGI-1776 通过 Pim-1 依赖和非依赖的机制降低细胞表面 P-糖蛋白(ABCB1)和乳腺癌耐药蛋白(ABCG2)的表达和药物转运。
Biochem Pharmacol. 2013 Feb 15;85(4):514-24. doi: 10.1016/j.bcp.2012.12.006. Epub 2012 Dec 19.
7
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.新型细胞周期蛋白依赖性激酶抑制剂SNS-032在慢性淋巴细胞白血病中的作用机制
Blood. 2009 May 7;113(19):4637-45. doi: 10.1182/blood-2008-12-190256. Epub 2009 Feb 20.
8
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma.靶向 PIM 激酶增强舒尼替尼在肾细胞癌中的活性。
Br J Cancer. 2011 Nov 8;105(10):1563-73. doi: 10.1038/bjc.2011.426. Epub 2011 Oct 20.
9
PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).PIM 激酶对于慢性淋巴细胞白血病细胞的存活(PIM2/3)和 CXCR4 介导的微环境相互作用(PIM1)是必不可少的。
Mol Cancer Ther. 2014 May;13(5):1231-45. doi: 10.1158/1535-7163.MCT-13-0575-T. Epub 2014 Mar 21.
10
The novel anti-adipogenic effect and mechanisms of action of SGI-1776, a Pim-specific inhibitor, in 3T3-L1 adipocytes.Pim特异性抑制剂SGI-1776在3T3-L1脂肪细胞中的新型抗脂肪生成作用及作用机制
Int J Mol Med. 2016 Jan;37(1):157-64. doi: 10.3892/ijmm.2015.2415. Epub 2015 Nov 19.

引用本文的文献

1
Cohesin-mediated stabilization of the CCAN complex at kinetochores in mitosis.有丝分裂过程中黏连蛋白介导的着丝粒处CCAN复合体的稳定。
Curr Biol. 2025 Jul 22. doi: 10.1016/j.cub.2025.07.011.
2
PIM1 kinase and its diverse substrate in solid tumors.PIM1 激酶及其在实体瘤中的多种底物。
Cell Commun Signal. 2024 Nov 1;22(1):529. doi: 10.1186/s12964-024-01898-y.
3
A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1.靶向 PIM1 的天然产物在弥漫性大 B 细胞淋巴瘤治疗中的应用前景。
Ann Hematol. 2024 Aug;103(8):2905-2915. doi: 10.1007/s00277-024-05670-7. Epub 2024 Mar 1.
4
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models.S100A8/A9可预测三阴性乳腺癌小鼠模型对PIM激酶和PD-1/PD-L1抑制的反应。
Commun Med (Lond). 2024 Feb 20;4(1):22. doi: 10.1038/s43856-024-00444-8.
5
PIM3 Kinase: A Promising Novel Target in Solid Cancers.PIM3激酶:实体癌中一个有前景的新型靶点。
Cancers (Basel). 2024 Jan 26;16(3):535. doi: 10.3390/cancers16030535.
6
PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.PIM1 靶向降解可防止前列腺癌产生耐药性。
Cell Chem Biol. 2024 Feb 15;31(2):326-337.e11. doi: 10.1016/j.chembiol.2023.10.023. Epub 2023 Nov 27.
7
An overview of pim kinase as a target in multiple myeloma.作为多发性骨髓瘤靶点的 Pim 激酶概述。
Cancer Med. 2023 May;12(10):11746-11759. doi: 10.1002/cam4.5797. Epub 2023 May 10.
8
When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases.当只有一个磷酸盐也太多时:Myc 和激酶之间的多方面相互作用。
Int J Mol Sci. 2023 Mar 1;24(5):4746. doi: 10.3390/ijms24054746.
9
Targeting Pim kinases in hematological cancers: molecular and clinical review.靶向血液系统恶性肿瘤的 Pim 激酶:分子与临床综述。
Mol Cancer. 2023 Jan 25;22(1):18. doi: 10.1186/s12943-023-01721-1.
10
Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy.针对多房棘球蚴 PIM 激酶提高抗寄生虫化疗效果。
PLoS Negl Trop Dis. 2022 Oct 3;16(10):e0010483. doi: 10.1371/journal.pntd.0010483. eCollection 2022 Oct.

本文引用的文献

1
PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.PIM-1特异性单克隆抗体通过降低PIM-1水平、减少Akt磷酸化和激活凋亡来抑制人和小鼠肿瘤生长。
J Clin Invest. 2009 Feb;119(2):362-75. doi: 10.1172/JCI33216. Epub 2009 Jan 19.
2
Mcl-1: the 1 in CLL.髓细胞白血病-1:慢性淋巴细胞白血病中的关键因素。 (注:原英文表述比较简略模糊,此译文是根据常见医学语境进行的意译,使其更符合中文表达习惯且传达出一定医学含义,仅为满足翻译需求,实际含义可能需结合更多背景信息。) 不过按照要求严格翻译的话:髓细胞白血病-1:慢性淋巴细胞白血病中的那个“1” 。
Blood. 2008 Nov 1;112(9):3538-40. doi: 10.1182/blood-2008-07-170241.
3
Targeting FLT3 for the treatment of leukemia.靶向FLT3治疗白血病。
Semin Hematol. 2008 Jul;45(3 Suppl 2):S17-21. doi: 10.1053/j.seminhematol.2008.07.007.
4
Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.PIM1激酶在人类癌症中的潜在作用——分子与治疗评估
Eur J Cancer. 2008 Oct;44(15):2144-51. doi: 10.1016/j.ejca.2008.06.044. Epub 2008 Aug 18.
5
Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphoma.致癌蛋白激酶Pim-1水平升高可在培养细胞中诱导p53通路,且与套细胞淋巴瘤中Mdm2增加相关。
J Biol Chem. 2008 Jun 27;283(26):18012-23. doi: 10.1074/jbc.M709695200. Epub 2008 May 8.
6
Pim kinase-dependent inhibition of c-Myc degradation.吡咯并嘧啶激酶依赖性抑制c-Myc降解。
Oncogene. 2008 Aug 14;27(35):4809-19. doi: 10.1038/onc.2008.123. Epub 2008 Apr 28.
7
The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells.44千道尔顿的Pim-1激酶使乳腺癌耐药蛋白/三磷酸腺苷结合盒转运体G2(BCRP/ABCG2)磷酸化,从而促进其在人前列腺癌细胞中的多聚化及耐药活性。
J Biol Chem. 2008 Feb 8;283(6):3349-3356. doi: 10.1074/jbc.M707773200. Epub 2007 Dec 5.
8
Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene.Pim-1和Pim-2激酶是v-Abl癌基因高效转化前B细胞所必需的。
Blood. 2008 Feb 1;111(3):1677-85. doi: 10.1182/blood-2007-04-083808. Epub 2007 Nov 27.
9
Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA.组成型激活的神经营养因子受体deltaTrkA具有显著的致白血病潜能和特性。
Leukemia. 2007 Oct;21(10):2171-80. doi: 10.1038/sj.leu.2404882. Epub 2007 Aug 2.
10
PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.MYC依赖的转录激活和致癌转化需要PIM1依赖的组蛋白H3丝氨酸10位点的磷酸化。
Nat Cell Biol. 2007 Aug;9(8):932-44. doi: 10.1038/ncb1618. Epub 2007 Jul 22.